Citations

Mayo Clinic

Showing 10 of 108602 citations.

Outcomes of Vaginal Hysterectomy With and Without Perceived Contraindications to Vaginal Surgery
Schmitt, Jennifer, Occhino, John A. , Weaver, Amy L. , McGree, Michaela E. , Gebhart, John B.

Female Pelvic Medicine & Reconstructive Surgery | September 14, 2017 | Volume: 25 | Issue: 1 | Pages: 41-48

10.1097/spv.0000000000000469 | PMID 28914709 Get It

Objective The aim of this study was to compare outcomes of vaginal hysterectomy between patients with and without the following perceived contraindications to vaginal surgery: uterine weight greater than 280 g, prior cesarean delivery, no vaginal parity, and obesity. Methods Retrospective cohort of benign vaginal hysterectomies between 2009 and 2013 was obtained. Outcomes included uterine debulking, transfusion, intraoperative complications, length of stay, and Accordion grade 2+ postoperative complications. For each outcome, the association between the presence of each contraindication and the outcome was evaluated using univariate and multivariate logistic regression models. Results Among 692 vaginal hysterectomies, 11% (76/691) had a uterine weight greater than 280 g, 11.3% (78/690) had no vaginal parity, 14.9% (103/690) had a history of cesarean delivery, and 37.7% (248/657) had a body mass index of 30 kg/m2 or greater; 110 (15.9%) had 2 or more contraindications. Uterine debulking occurred in 146 women (21.1%), and both uterine weight greater 280 g (adjusted odds ratio, 39.2; 95% confidence interval, 18.4–83.5) and prior cesarean delivery (adjusted odds ratio, 2.1; 95% confidence interval, 1.2–3.7) were significantly associated with an increased likelihood of uterine debulking after adjusting for age, hematologic disease, and preoperative diagnosis. None of the contraindications were significantly associated with need for a blood transfusion, presence of an intraoperative complication, length of stay greater than 2 days, or presence of an Accordion grade 2+ postoperative complication, which occurred in 2.7%, 2.5%, 14.0%, and 6.9% of all women, respectively. Conclusions Vaginal hysterectomy can be safely performed with favorable outcomes, even in women with a uterus greater than 280 g, prior cesarean delivery, no vaginal parity, and obesity. Our findings challenge several perceived contraindications to vaginal hysterectomy.
Diffuse Staining for Activated NOTCH1 Correlates With NOTCH1 Mutation Status and Is Associated With Worse Outcome in Adenoid Cystic Carcinoma
Sajed, Dipti P. , Carey, Christopher D. , Severson, Eric A. , Afrogheh, Amir , Blacklow, Stephen C. , Chau, Nicole G. , Lin, Derrick T., García, Joaquín J. , Sholl, Lynette M. , Faquin, William C , Johnson, Carl A., Krane, Jeffrey F. , Jo, Vickie Y. , Aster, Jon Christopher

American Journal of Surgical Pathology | September 14, 2017 | Volume: 41 | Issue: 11 | Pages: 1473-1482

10.1097/pas.0000000000000945 | PMID 28914715 Get It

NOTCH1 is frequently mutated in adenoid cystic carcinoma (ACC). To test the idea that immunohistochemical (IHC) staining can identify ACCs with NOTCH1 mutations, we performed IHC for activated NOTCH1 (NICD1) in 197 cases diagnosed as ACC from 173 patients. NICD1 staining was positive in 194 cases (98%) in 2 major patterns: subset positivity, which correlated with tubular/cribriform histology; and diffuse positivity, which correlated with a solid histology. To determine the relationship between NICD1 staining and NOTCH1 mutational status, targeted exome sequencing data were obtained on 14 diffusely NICD1-positive ACC specimens from 11 patients and 15 subset NICD1-positive ACC specimens from 15 patients. This revealed NOTCH1 gain-of-function mutations in 11 of 14 diffusely NICD1-positive ACC specimens, whereas all subset-positive tumors had wild-type NOTCH1 alleles. Notably, tumors with diffuse NICD1 positivity were associated with significantly worse outcomes (P=0.003). To determine whether NOTCH1 activation is unique among tumors included in the differential diagnosis with ACC, we performed NICD1 IHC on a cohort of diverse salivary gland and head and neck tumors. High fractions of each of these tumor types were positive for NICD1 in a subset of cells, particularly in basaloid squamous cell carcinomas; however, sequencing of basaloid squamous cell carcinomas failed to identify NOTCH1 mutations. These findings indicate that diffuse NICD1 positivity in ACC correlates with solid growth pattern, the presence of NOTCH1 gain-of-function mutations, and unfavorable outcome, and suggest that staining for NICD1 can be helpful in distinguishing ACC with solid growth patterns from other salivary gland and head and neck tumors.
Cancer-associated weight loss: releasing its firm grip on negative clinical outcomes
Yusuf, Naima, Jatoi, Aminah

Current Opinion in Supportive & Palliative Care | September 13, 2017 | Volume: 11 | Issue: 4 | Pages: 259-260

10.1097/spc.0000000000000297 | PMID 28914643 Get It

In-Hospital Outcomes of Tumor Lysis Syndrome: A Population-Based Study Using the National Inpatient Sample
Durani, Urshila , Shah, Nilay D. , Go, Ronald S. , Durani, Urshila

The Oncologist | September 13, 2017 | Volume: 22 | Issue: 12 | Pages: 1506-1509

10.1634/theoncologist.2017-0147 | PMID 28904174 Get It

Abstract The epidemiology and outcomes of tumor lysis syndrome (TLS) are understudied. We used the National Inpatient Sample (NIS), a nationally representative weighted sample of all U.S. hospital discharges, to study outcomes and predictors of mortality in hospitalized patients with TLS. The NIS was queried for patients with a discharge diagnosis of TLS (ICD-9 code 277.88) from 2010–2013. Baseline characteristics and outcomes were analyzed. A multivariable logistic regression analysis was performed to identify predictors of mortality. From 2010–2013, 28,370 patients were discharged with a diagnosis of TLS. The most common malignancies were non-Hodgkin lymphoma (30%), solid tumors (20%), acute myeloid leukemia (19%), and acute lymphocytic leukemia (13%). Overall in-hospital mortality was 21%. The median length of stay was 10 days (IQR 5-22). Sixty-nine percent of patients experienced a severe complication, including sepsis (22%, 95% confidence interval [CI] 21–23), dialysis (15%, 95% CI 14–16), acute respiratory failure (23%, 95% CI 22–24), mechanical ventilation (16%, 95% CI 15–17), gastrointestinal hemorrhage (6%, 95% CI 5–7), cerebral hemorrhage (2%, 95% CI 2–3), seizures (1%, 95% CI 0.6–1), and cardiac arrest (2%, 95% CI 2–3). Predictors of mortality were derived from a multivariable logistic regression and included age, Elixhauser comorbidity score, insurance status, teaching versus nonteaching hospital, and cancer type. Predictors of increased length of stay included age, race, teaching versus nonteaching hospital, and cancer type. In the U.S., many patients with TLS develop life-threatening complications and a quarter die during hospitalization. As more cancer treatments become available, strategies to improve the supportive care of patients with TLS should be a priority.
Efficacy of Antitoxin Therapy in Treating Patients With Foodborne Botulism: A Systematic Review and Meta-analysis of Cases, 1923–2016
O’Horo, John C. , Harper, Eugene P. , Rafei, Abdelghani El , Ali, Rashid , Sakusic, Amra , Saleh, Omar Abu , Marcelin, Jasmine R , Rao, Agam K. , Sobel, Jeremy, Tosh, Pritish K. , El Rafei, Abdelghani, Abu Saleh, Omar M, Tan, Eugene M. , Marcelin, Jasmine , O'Horo, John C , DeSimone, Daniel C.

Clinical Infectious Diseases | September 13, 2017 | Volume: 66 | Issue: suppl_1 | Pages: S43-S56

10.1093/cid/cix815 | PMID 29293927 Get It

Detecting myocardial infarction type 2: targetting the right patients
Thygesen, Kristian , Jaffe, Allan S. , Jaffe, Allan S.

European Heart Journal | September 13, 2017 | Volume: 38 | Issue: 47 | Pages: 3521-3522

10.1093/eurheartj/ehx557 | PMID 29029142 Get It

Oncologic Safety of Prophylactic Nipple-Sparing Mastectomy in a Population With BRCA Mutations
Jakub, James W. , Peled, Anne Warren, Gray, Richard J. , Greenup, Rachel A., Sacchini, Virgilio , McLaughlin, Sarah A. , Tchou, Julia , Vierkant, Robert A. , Jakub, James W , Vierkant, Robert A , Kiluk, John V. , Degnim, Amy C. , Willey, Shawna C.

JAMA Surgery | September 13, 2017 | Volume: 153 | Issue: 2 | Pages: 123

10.1001/jamasurg.2017.3422 | PMID 28903167 Get It

Identification of Stroke Mimics in the Emergency Department Setting
Hentz, Joseph G. , Bobrow, Bentley J., Tobin, W. Oliver , Demaerschalk, Bart M.

Journal of brain disease | September 13, 2017 | Volume: 1 | Issue: No issue available | Pages: JCNSD.S2280

10.4137/jcnsd.s2280 | PMID 23818805 Get It

Background and Purpose Previous studies have shown a stroke mimic rate of 9%–31%. We aimed to establish the proportion of stroke mimics amongst suspected acute strokes, to clarify the aetiology of stroke mimic and to develop a prediction model to identify stroke mimics. Methods This was a retrospective cohort observational study. Consecutive “stroke alert” patients were identified over nine months in a primary stroke centre. 31 variables were collected. Final diagnosis was defined as “stroke” or “stroke mimic”. Multivariable regression analysis was used to define clinical predictors of stroke mimic. Results 206 patients were reviewed. 22% were classified as stroke mimics. Multivariable scoring did not help in identification of stroke mimics. 99.5% of patients had a neurological diagnosis at final diagnosis. Discussion 22% of patients with suspected acute stroke had a stroke mimic. The aetiology of stroke mimics was varied, with seizure, encephalopathy, syncope and migraine being commonest. Multivariable scoring for identification of stroke mimics is not feasible. 99.5% of patients had a neurological diagnosis. This strengthens the case for the involvement of stroke neurologists/stroke physicians in acute stroke care.
Views of Emergency Physicians on Thrombolysis for Acute Ischemic Stroke
Bobrow, Bentley J., Villarin, A., Clark, Lani, JENNINGS, A.M.C., Demaerschalk, Bart M. , Wood, Joseph P.

Journal of brain disease | September 13, 2017 | Volume: 1 | Issue: No issue available | Pages: JCNSD.S2231

10.4137/jcnsd.s2231 | PMID 23818807 Get It

Background The 3-hour window for treating stroke with intravenous tissue plasminogen activator (t-PA) requires well-organized, integrated efforts by emergency physicians and stroke neurologists. Objective To evaluate attitudes and knowledge of emergency physicians about intravenous t-PA for acute ischemic stroke, particularly in primary stroke centers (PSCs) with stroke neurology teams. Methods A 15-question pilot Internet survey administered by the Arizona College of Emergency Physicians. Results Between March and August 2005, 100 emergency physicians responded: 71 in Arizona and 29 in Missouri. Forty-eight percent practiced at PSCs; 48% thought t-PA was effective, 20% did not, and 32% were uncertain. PSC or non-PSC location of practice did not influence endorsement (odds ratio, 0.96; 95% confidence interval, 0.27–1.64). Of those opposing t-PA, 87% cited risk of hemorrhage. Conclusions Most emergency physicians did not endorse t-PA. Improved collaboration between emergency physicians and stroke neurologists is needed.